Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; ...

Sepsis induces a complex interplay between inflammation and coagulation, leading to haemostatic dysregulation. Pathogen-triggered cytokine release activates endothelial cells and platelets, promoting ...

Non-compressible hemorrhage control is a challenging topic both on the battlefield and in civilian life. Various forms of hemostatic materials have been designed. Different researchers design their ...

A new spray-on powder developed by KAIST can stop life-threatening bleeding in about one second by instantly forming a strong gel over a wound. It works on deep and irregular injuries where ...

The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major participated, has tackled this issue head-on. By developing a next-generation ...

Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as the liver or spleen are especially dangerous because bleeding is difficult to ...

Incyte Corporation INCY said Monday it has agreed to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal valued at $1.25 billion upfront. The transaction will add late ...

The recommendations aim to make this type of evaluation more consistent in cases when children have suspicious bruising or bleeding patterns. “When bleeding or bruising is suspicious for child abuse, ...

As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...